Researchers at the Fred Hutchinson Cancer Research Center have identified genetic markers associated with aggressive prostate cancer. They say their work could lead to the development of a simple blood test that could help determine who should receive aggressive treatment and who could opt for more conservative approaches.
Drs. Elahe Mostaghel and Jason Bielas recently received New Investigator Awards from the Department of Defense’s Prostate Cancer Research Program. Bielas, an investigator in the Public Health Sciences Division, will use his three-year, $365,000 grant to develop a blood-based, non-invasive screening
Click here to listen to an interview of Pete Nelson conducted by NPR station KPLU. SEATTLE, WA (KPLU) - For men diagnosed with prostate cancer the best course of action may be no treatment at all. KPLU
Researchers at the Hutchinson Center have a lead role in a new public/private partnership to create the first systematic surveillance program of men with prostate cancer to look for biological clues to help determine when to wait and
From promising new medications and imaging techniques to improved understanding of molecular features and disease predictors, Hutchinson Center scientists are gaining ground in battling prostate cancer, the second leading cause of cancer deaths in men. An estimated 218,800 American